[go: up one dir, main page]

UA81649C2 - Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие - Google Patents

Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие

Info

Publication number
UA81649C2
UA81649C2 UAA200506234A UA2005006234A UA81649C2 UA 81649 C2 UA81649 C2 UA 81649C2 UA A200506234 A UAA200506234 A UA A200506234A UA 2005006234 A UA2005006234 A UA 2005006234A UA 81649 C2 UA81649 C2 UA 81649C2
Authority
UA
Ukraine
Prior art keywords
carbamic acid
acid esters
anticholinergic action
anticholinergic
relates
Prior art date
Application number
UAA200506234A
Other languages
English (en)
Ukrainian (uk)
Inventor
Маттиас Хоффманн
Михаэль П. Пипер
Георг Шпек
Штеффен Брайтфельдер
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of UA81649C2 publication Critical patent/UA81649C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В заявке описаны новые эфиры карбаминовой кислоты общей формулы (1)в которой Xи группы A, R, R, Rи Rмогут иметь указанные в формуле изобретения и в описании значения, а также описаны способ их получения и их применение как лекарственных средств, прежде всего лекарственных средств, которые имеют антихолинергическое действие.
UAA200506234A 2002-11-26 2003-11-19 Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие UA81649C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit
PCT/EP2003/012912 WO2004048373A1 (de) 2002-11-26 2003-11-19 Carbaminsäureester mit anticholinerger wirksamkeit

Publications (1)

Publication Number Publication Date
UA81649C2 true UA81649C2 (ru) 2008-01-25

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200506234A UA81649C2 (ru) 2002-11-26 2003-11-19 Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие

Country Status (20)

Country Link
EP (1) EP1567526B1 (ru)
JP (1) JP4754829B2 (ru)
KR (1) KR20050086821A (ru)
CN (1) CN1717408A (ru)
AT (1) ATE392424T1 (ru)
AU (1) AU2003289880A1 (ru)
BR (1) BR0316549A (ru)
CA (1) CA2507110C (ru)
DE (2) DE10255040A1 (ru)
EA (1) EA200500775A1 (ru)
EC (1) ECSP055803A (ru)
ES (1) ES2304538T3 (ru)
HR (1) HRP20050465A2 (ru)
MX (1) MXPA05005443A (ru)
NO (1) NO20053089L (ru)
PL (1) PL376638A1 (ru)
RS (1) RS20050384A (ru)
UA (1) UA81649C2 (ru)
WO (1) WO2004048373A1 (ru)
ZA (1) ZA200502946B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106333A1 (en) * 2003-05-28 2004-12-09 Theravance, Inc. Azabicycloalkane compounds as muscarinic receptor antagonists
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US20080287487A1 (en) * 2004-06-30 2008-11-20 Anthony William James Cooper Muscarinic Acetylcholine Receptor Antagonists
EP1827439A4 (en) * 2004-11-15 2009-11-18 Glaxo Group Ltd NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
EP1904446A2 (en) * 2005-07-11 2008-04-02 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
WO2007068929A1 (en) * 2005-12-16 2007-06-21 Argenta Discovery Ltd. Cyclic amine derivatives and their uses
CN101605784B (zh) 2007-02-09 2013-04-10 安斯泰来制药株式会社 氮杂桥环化合物
PH12020550215B1 (en) 2017-10-05 2023-05-19 Fulcrum Therapeutics Inc P38 Kinase Inhibitors Reduce Dux4 And Downstream Gene Expression For The Treatment Of Fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
US11548931B2 (en) 2017-11-16 2023-01-10 Xl-Protein Gmbh PASylated VEGFR/PDGFR fusion proteins and their use in therapy
WO2019110521A1 (en) 2017-12-04 2019-06-13 Friedrich-Alexander-Universität Erlangen-Nürnberg Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
EP0747355A4 (en) * 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd NEW CARBAMATES AND MEDICINAL PRODUCTS CONTAINING THEM
WO1997034892A1 (en) * 1996-03-20 1997-09-25 Wake Forest University Sigma-2 receptors as biomarkers of tumor cell proliferation

Also Published As

Publication number Publication date
AU2003289880A1 (en) 2004-06-18
ZA200502946B (en) 2005-11-23
NO20053089D0 (no) 2005-06-23
NO20053089L (no) 2005-06-23
MXPA05005443A (es) 2005-08-03
ES2304538T3 (es) 2008-10-16
CN1717408A (zh) 2006-01-04
JP2006514010A (ja) 2006-04-27
DE10255040A1 (de) 2004-06-03
PL376638A1 (pl) 2006-01-09
CA2507110A1 (en) 2004-06-10
CA2507110C (en) 2012-07-10
KR20050086821A (ko) 2005-08-30
BR0316549A (pt) 2005-10-04
WO2004048373A1 (de) 2004-06-10
JP4754829B2 (ja) 2011-08-24
EP1567526A1 (de) 2005-08-31
RS20050384A (en) 2007-12-31
EA200500775A1 (ru) 2005-12-29
HRP20050465A2 (en) 2006-10-31
EP1567526B1 (de) 2008-04-16
ECSP055803A (es) 2005-08-11
ATE392424T1 (de) 2008-05-15
DE50309655D1 (de) 2008-05-29

Similar Documents

Publication Publication Date Title
RS65604A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
RS59404A (en) Method for producing scopine esters
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
RS20050361A (en) Novel medicament for the treatment of chronic obstructive pulmonary diseases
ZA200604719B (en) DPP-IV inhibitors
EP1604989A8 (en) DPP-IV inhibitors
WO2006008028A8 (de) Neue 6-formyl-tetrahydropteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, u.a. gegen krebs
WO2003032994A3 (de) 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
UA81649C2 (ru) Эфиры карбаминовой кислоты, которые имеют антихолинергическое действие
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
EP1604980A8 (en) DPP-IV inhibitors
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2003082757A3 (en) Methods of modifying fibers
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
MX2007005874A (es) Diamidas del acido n-heterociclil-ftalico como insecticidas.
BG106916A (en) Method for producing aryl-iminomethyl-carbamic acid esters
RS20060049A (en) Novel n-substituted indolyl-3-glycoxylic acid amides, use thereof as a medicament and method for the production thereof
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.
HRP20050791A2 (en) Nitrate esters of phenylaminothiophenacetic acid derivatives
UA83715C2 (ru) Оптически активные карбоксамиды и способ борьбы с нежелательными микроорганизмами